Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Clinical questions are handled by the in-app care team, not phone or email
RCT SCALE Study - Liraglutide vs Placebo for Weight Loss in Overweight Nondiabetic Adults, NEJM (2015) [PubMed abstract] The SCALE study enrolled 3731 overweight adults who did not have diabetes Main inclusion criteria BMI 30
Key Points Research into the effect of semaglutide on breastfeeding is still emerging, but initial studies suggest minimal risk to breastfed babies Oral semaglutide (Rybelsus), however, is specifically not recommended during breastfeeding While early evidence is reassuring, long-term effects on infants remain unknown Healthcare providers still recommend caution and individualized decision-making You've heard about semaglutide's impressive weight loss results
rising heart rate or heavy fatigue argues against further escalation
L.DingC
US$ 21.92
US$ 23.43
US$ 20.92
US$ 24.22
US$ 23.00
